Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Unravel Biosciences announced it raised $4.1 Million in an initial filing from an offering of $4.5 Million
PRIVATEAug 24, 2026•about 3 hours ago
Amount Raised
$4.1 Million
Round Type
Seed
BostonBiotechnology
Company Information
Company
Unravel Biosciences, Inc.
Location
100 WILLIAM T. MORRISSEY BLVD.
Boston, Massachusetts, United States
About
Diseases are a product of complex interactions among biological layers that we barely understand. Our platform integrates computational drug prediction with on-demand animal models and cutting-edge screening hardware to rapidly connect behavioral and cognitive symptoms to novel therapeutic targets and treatments in a matter of weeks. Unlike other discovery stage companies, Unravel enables unbiased identification of drug targets that span organ systems, including restoring metabolism and reducing inflammation.
Don't miss Unravel Biosciences, Inc.'s next move
Get an email the moment Unravel Biosciences, Inc. raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Verified contactsRichard N., Executive Officer, Director hidden
Predictive Intelligence
Strategic
ML-powered predictions for Unravel Biosciences, Inc.'s next move